Bagnasco, D.; Savarino, E.V.; Yacoub, M.-R.; Braido, F.; Candeliere, M.G.; Giannini, E.; Passalacqua, G.; Marabotto, E.
Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target Therapy. Pharmaceutics 2023, 15, 2359.
https://doi.org/10.3390/pharmaceutics15092359
AMA Style
Bagnasco D, Savarino EV, Yacoub M-R, Braido F, Candeliere MG, Giannini E, Passalacqua G, Marabotto E.
Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target Therapy. Pharmaceutics. 2023; 15(9):2359.
https://doi.org/10.3390/pharmaceutics15092359
Chicago/Turabian Style
Bagnasco, Diego, Edoardo Vincenzo Savarino, Mona-Rita Yacoub, Fulvio Braido, Maria Giulia Candeliere, Edoardo Giannini, Giovanni Passalacqua, and Elisa Marabotto.
2023. "Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target Therapy" Pharmaceutics 15, no. 9: 2359.
https://doi.org/10.3390/pharmaceutics15092359
APA Style
Bagnasco, D., Savarino, E. V., Yacoub, M.-R., Braido, F., Candeliere, M. G., Giannini, E., Passalacqua, G., & Marabotto, E.
(2023). Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target Therapy. Pharmaceutics, 15(9), 2359.
https://doi.org/10.3390/pharmaceutics15092359
